Dossier
Ichnos Glenmark Innovation
Coverage of Ichnos Glenmark Innovation in the Nexus archive.
- STAT+: Up and down the ladder: The latest comings and goings
Ichnos Glenmark Innovation hired Mariana Cota Stirner as chief medical officer. She previously served as fractional chief medical officer and head of clinical development at Azalea Therapeutics and as vice president and therapeutic area head of hematology at AbbVie.